Pregnancy outcome following in utero exposure to bisphosphonates.
暂无分享,去创建一个
G. Koren | S. Ito | D. Matsui | J. Han | M. Moretti | Nobuko Taguchi | I. Fayez | S. Levy | J. Aiello
[1] A. Ornoy,et al. The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. , 2006, Reproductive toxicology.
[2] D. Chitayat,et al. Prenatal diagnosis of Apert syndrome: report of two cases , 2003, Prenatal diagnosis.
[3] N. Watts. Bisphosphonate treatment of osteoporosis. , 2003, Clinics in geriatric medicine.
[4] A. R. Rutgers-Verhage,et al. No effects of bisphosphonates on the human fetus. , 2003, Birth defects research. Part A, Clinical and molecular teratology.
[5] T. Srivastava,et al. Bisphosphonates: From Grandparents to Grandchildren , 1999, Clinical pediatrics.
[6] G. Golomb,et al. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. , 1999, Teratology.
[7] F. Glorieux,et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. , 1998, The New England journal of medicine.
[8] Jacques P. Brown,et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .
[9] P. Delmas,et al. Long‐Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone , 1997, Lancet.
[10] S. Papapoulos,et al. Long‐Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe Osteoporosis , 1997, Medicine.
[11] J. Lin,et al. Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.
[12] U. Liberman,et al. Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease. , 1994, Pediatrics.
[13] P. Delmas,et al. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone , 1994, The Lancet.
[14] P. Bentley,et al. Reproduction toxicity studies with pamidronate. , 1992, Arzneimittel-Forschung.
[15] D. Dunlop,et al. Antenatal administration of aminopropylidene diphosphonate. , 1990, Annals of the rheumatic diseases.
[16] T. Illidge,et al. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).